Your browser doesn't support javascript.
loading
European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure.
Sacco, Simona; Lampl, Christian; Amin, Faisal Mohammad; Braschinsky, Mark; Deligianni, Christina; Uludüz, Derya; Versijpt, Jan; Ducros, Anne; Gil-Gouveia, Raquel; Katsarava, Zaza; Martelletti, Paolo; Ornello, Raffaele; Raffaelli, Bianca; Boucherie, Deirdre M; Pozo-Rosich, Patricia; Sanchez-Del-Rio, Margarita; Sinclair, Alexandra; Maassen van den Brink, Antoinette; Reuter, Uwe.
Afiliação
  • Sacco S; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Via Vetoio 1, L'Aquila, Italy. simona.sacco@univaq.it.
  • Lampl C; Department of Neurology, Headache Medical Center at the Konventhospital BHB Linz, Linz, Austria.
  • Amin FM; Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, University of Copenhagen, Copenhagen, Denmark.
  • Braschinsky M; Department of Neurorehabilitation/Traumatic Brain Injury, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Deligianni C; Department of Neurology, Institute of Clinical Medicine, University of Tartu; Headache Clinic, Department of Neurology, Tartu University Hospital, Tartu, Estonia.
  • Uludüz D; Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, University of Copenhagen, Copenhagen, Denmark.
  • Versijpt J; Department of Neurology Istanbul Cerrahpasa Medical Faculty, Istanbul, Turkey.
  • Ducros A; Department of Neurology, Vrije Universiteit Brussel (VUB), Universitair, Ziekenhuis Brussel, Brussels, Belgium.
  • Gil-Gouveia R; Neurology Department, CHU de Montpellier Charles Coulomb Laboratory, Montpellier University, Montpellier, France.
  • Katsarava Z; Neurology Department, Hospital da Luz Headache Center, Hospital da Luz, Lisbon, Portugal.
  • Martelletti P; Center for Interdisciplinary Research in Health, Universidade Católica Portuguesa, Lisbon, Portugal.
  • Ornello R; Christian Hospital, Unna, Germany.
  • Raffaelli B; University of Duisburg-Essen, Essen, Germany.
  • Boucherie DM; Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy.
  • Pozo-Rosich P; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Via Vetoio 1, L'Aquila, Italy.
  • Sanchez-Del-Rio M; Department of Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Sinclair A; Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Maassen van den Brink A; Headache Unit, Neurology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Reuter U; Department of Medicine, Headache and Neurological Pain Research Group, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
J Headache Pain ; 23(1): 133, 2022 Oct 12.
Article em En | MEDLINE | ID: mdl-36224519
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Triptaminas / Transtornos de Enxaqueca Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Triptaminas / Transtornos de Enxaqueca Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article